VTR - Ventas, Inc.
NYSE
->
Real Estate
->
REIT—Healthcare Facilities
Chicago,
United States
Type: Equity
VTR price evolution
VTR
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $615.28 | $688.41 | $563.46 | |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $1104.73 | $557.08 | $632.44 | $508.79 |
| Long term investments | ||||
| Property, plant & equipment | $21510.26 | $22121.97 | $21550.81 | $22375.14 |
| Goodwill & intangible assets | $1045.07 | $1045.05 | $1045.18 | |
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $25347.19 | $24530.23 | $24672.59 | $24725.43 |
| Current liabilities | ||||
| Accounts payable | $1148.75 | $1003.08 | $1020.31 | $1041.62 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $1534.96 | $1528.51 | $2512.89 | $1353.75 |
| Long term debt | $13611.86 | $12984.89 | $12387.97 | $13490.9 |
| Total noncurrent liabilities | ||||
| Total debt | $13388.19 | $13757.39 | $13685.63 | |
| Total liabilities | $15258.41 | $14551.05 | $14984.7 | $14878.39 |
| Shareholders' equity | ||||
| Retained earnings | -$6748.22 | -$6577.4 | -$6410.14 | -$6213.8 |
| Other shareholder equity | $292.32 | -$17.41 | $266.63 | -$35.76 |
| Total shareholder equity | $9619.35 | $9402.84 | $9488.06 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $563.46 | $170.75 | $196.6 | $451.64 |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $508.79 | $122.56 | $149.72 | $688.04 |
| Long term investments | $844.83 | |||
| Property, plant & equipment | $22375.14 | $21160.45 | $22870.43 | $21599.29 |
| Goodwill & intangible assets | $1045.18 | $1044.41 | $1046.14 | $1051.65 |
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $24725.43 | $24157.84 | $24717.79 | $23929.4 |
| Current liabilities | ||||
| Accounts payable | $1041.62 | $1031.69 | $1090.25 | $1133.07 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $1353.75 | $1332.67 | $1394.09 | $1128.44 |
| Long term debt | $13490.9 | $12296.78 | $12027.54 | $11895.41 |
| Total noncurrent liabilities | ||||
| Total debt | $13685.63 | $12487.22 | $12224.78 | $12105.33 |
| Total liabilities | $14878.39 | $13740.22 | $13491.74 | $13415.72 |
| Shareholders' equity | ||||
| Retained earnings | -$6213.8 | -$5449.39 | -$4679.89 | -$4030.38 |
| Other shareholder equity | -$35.76 | $227.85 | -$64.52 | -$54.35 |
| Total shareholder equity | $9488.06 | $10152.97 | $10854.39 | $10180.17 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1236.32 | $1200.98 | $1199.91 | $1164.39 |
| Cost of revenue | $681.8 | $689.25 | $669.41 | |
| Gross Profit | $521.35 | $519.18 | $510.66 | $494.99 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $37.73 | $48.74 | $36.38 | |
| Total operating expenses | $322.06 | $388.58 | $367.98 | $452.98 |
| Operating income | $130.59 | $142.68 | $42 | |
| Income from continuing operations | ||||
| EBIT | $176.41 | $132.62 | $68.73 | |
| Income tax expense | $3 | $7.77 | -$3 | $4.7 |
| Interest expense | -$147.3 | $149.26 | $149.93 | $154.85 |
| Net income | ||||
| Net income | $19.24 | $19.39 | -$14.31 | -$90.82 |
| Income (for common shares) | $19.39 | -$14.31 | -$90.82 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4497.83 | $4129.19 | $3828.01 | $3795.36 |
| Cost of revenue | $2561.25 | $2282.92 | $2088.5 | $1939.76 |
| Gross Profit | $1936.58 | $1846.28 | $1739.51 | $1855.6 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $148.88 | $144.87 | $129.76 | $130.16 |
| Total operating expenses | $1484.15 | $1472.27 | $1402.51 | $1294.68 |
| Operating income | $452.43 | $374 | $337 | $560.92 |
| Income from continuing operations | ||||
| EBIT | $523.6 | $403.18 | $493.92 | $812.16 |
| Income tax expense | -$9.54 | -$16.93 | $4.83 | -$96.53 |
| Interest expense | $574.11 | $467.56 | $440.09 | $469.54 |
| Net income | ||||
| Net income | -$40.97 | -$47.45 | $49.01 | $439.15 |
| Income (for common shares) | -$40.97 | -$47.45 | $49.01 | $439.15 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $19.39 | -$14.31 | -$90.82 | |
| Operating activities | ||||
| Depreciation | $339.85 | $300.25 | $435.28 | |
| Business acquisitions & disposals | -$17.89 | -$11.18 | -$32.53 | |
| Stock-based compensation | $5.79 | $16.28 | $5.69 | |
| Total cash flows from operations | $335.87 | $266.45 | $279.08 | |
| Investing activities | ||||
| Capital expenditures | -$243.69 | -$130.2 | -$12.6 | |
| Investments | -$6.3 | -$4.96 | -$1.27 | |
| Total cash flows from investing | -$840.88 | -$266.8 | -$144.59 | -$43.28 |
| Financing activities | ||||
| Dividends paid | -$551.37 | -$182.31 | -$182.85 | -$181.32 |
| Sale and purchase of stock | $414.37 | $77.43 | ||
| Net borrowings | -$354.64 | $125.19 | $20.09 | |
| Total cash flows from financing | $489.02 | -$140.25 | $4.82 | -$165.46 |
| Effect of exchange rate | -$1.89 | -$1.95 | -$1.74 | $1.36 |
| Change in cash and equivalents | $602.24 | -$71.18 | $126.69 | $70.35 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$40.97 | -$47.45 | $49.01 | $439.15 |
| Operating activities | ||||
| Depreciation | $1392.46 | $1197.8 | $1197.4 | $1109.76 |
| Business acquisitions & disposals | -$5.8 | -$55.34 | -$111.44 | -$286.82 |
| Stock-based compensation | $30.99 | $30.71 | $31.97 | $21.49 |
| Total cash flows from operations | $1119.87 | $1120.16 | $1026.12 | $1450.18 |
| Investing activities | ||||
| Capital expenditures | -$249.94 | -$787.77 | -$961.58 | $437.06 |
| Investments | $41.88 | -$29.81 | $347.6 | $3.85 |
| Total cash flows from investing | -$184.66 | -$859.22 | -$724.14 | $154.29 |
| Financing activities | ||||
| Dividends paid | -$723.56 | -$720.32 | -$686.89 | -$928.81 |
| Sale and purchase of stock | $110.19 | $8.69 | $625.61 | $70.47 |
| Net borrowings | $97.75 | $468.8 | -$447.95 | -$409.01 |
| Total cash flows from financing | -$543.75 | -$283.93 | -$558.47 | -$1300.02 |
| Effect of exchange rate | $1.26 | -$2.87 | $1.45 | $1.09 |
| Change in cash and equivalents | $391.46 | -$22.98 | -$256.49 | $304.45 |
News
Fundamentals
| Market cap | $29.33B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 419.26M |
| Revenue | $4.80B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$66.50M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -441.07 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 6.11 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$0.16 |
|---|---|
| ROA | -0.27% |
| ROE | N/A |
| Debt/Equity | 1.57 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.72 |
| Quick ratio | N/A |